ACC017+FTC/TAF

DRUG2 trials

Sponsors

Jiangsu Aidea Pharmaceutical Group Co., Ltd.

Conditions

Infection, Human Immunodeficiency Virus

Phase 1

Phase Ib/IIa Clinical Study of ACC017 Tablets

CompletedNCT06719310

Jiangsu Aidea Pharmaceutical Group Co., Ltd.Infection, Human Immunodeficiency Virus

Start: 2024-08-28End: 2025-04-28Updated: 2026-08-14

Efficacy and Safety of ACC017 Tablets Compared With Dolutegravir Sodium Tablets in Treatment-Naïve Adults With Human Immunodeficiency Virus Type 1 (HIV-1)

RecruitingNCT07711223

Jiangsu Aidea Pharmaceutical Group Co., Ltd.Infection, Human Immunodeficiency Virus

Start: 2025-11-07End: 2028-12-31Target: 660Updated: 2026-07-17